Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells - Wikidata - awgldk - TriplyDB

Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

http://www.wikidata.org/entity/Q57942209

about

CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model Defining the extended substrate specificity of kallikrein 1-related peptidases.Substrate specificity of human kallikreins 1 and 6 determined by phage display.Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display.Pathogenesis of ovarian cancer: clues from selected overexpressed genes.Gene network analyses point to the importance of human tissue kallikreins in melanoma progression mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis.LIN28B promotes colon cancer progression and metastasis High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis.Hydrogel Microwell Arrays Allow the Assessment of Protease-Associated Enhancement of Cancer Cell Aggregation and Survival.MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma The kallikrein world: an update on the human tissue kallikreins.The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6.Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer.The autolytic regulation of human kallikrein-related peptidase 6.Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.Expression and biological significance of human kallikrein 6 in gastric cancer tissues.Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology.The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.Metastasis of ovarian cancer is mediated by kallikrein related peptidases.Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Vitronectin--master controller or micromanager?Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.Putative functions of tissue kallikrein-related peptidases in vaginal fluid.Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment.Regulation of human tissue kallikrein-related peptidase expression by steroid hormones in 32 cell lines.Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer.

P2860

Q28569526-D8EA9883-69D8-4086-89C7-E531B4692DE7 Q28742738-6CB17D5C-ADBF-43A1-8EF3-EAEAEA2E7AB7 Q33304675-56357B88-FC30-4118-9B49-D5E8C90F7C32 Q33325124-9E5D7110-9A97-42C7-BD03-ED9F5EA891A1 Q33382170-00BA322E-30F1-4B8F-9E79-2B15DFFD5F0C Q33651139-2E76DB62-6094-4311-8732-374DA0AAA14E Q34060071-9823BDF4-8E23-4887-88DD-36D00DB50320 Q34112686-228334E0-FF22-4C46-B9B1-68496E2BC1F0 Q35051058-59215084-1126-4F95-8B87-9D543469C171 Q35893466-7D9D26F0-0AA5-40B7-899C-3C814ECA8CAF Q36125886-DBA24347-7A8C-45FD-B0C7-586DC0A1F32A Q36235848-22FE6F8D-4AED-402F-B197-74F921D1EAC4 Q36519354-C0E9C03D-ED12-4B97-A9A2-40D3CAA87510 Q36519383-2C30CB18-AA3A-4265-9142-F4DC2CEA703B Q36560848-A37B36FA-BAC7-4B3E-B31B-7044A04674C1 Q36627182-F9AB6D32-3EC4-4C9B-9D33-D9D30DA5A202 Q36686826-483C22DC-7576-4785-8EAC-9D9953391587 Q36840687-0F2AA876-5A06-4F70-88CC-DC1C88E1A0AE Q36908718-2166BD91-2519-45F0-9534-CCD00B959CC4 Q36936018-C63463D2-3D49-4B36-8965-9AE09F8A4E4A Q36936734-A597F395-9CC1-4514-AD2C-8ECA80090767 Q36965062-EB3DB9F1-F4D3-409A-A102-9C447CF21FEF Q37216587-1A4F6FE6-B066-450F-9303-AF34662C0535 Q37272263-5DBD57BC-AE86-4156-9ECA-3767E092206C Q37400530-D7C50387-536D-45FC-8E40-16095D46B15A Q37480184-57CE89A0-96A8-4CB4-B134-689B86B42337 Q37697808-9DF55739-6B50-4D89-8E15-EDE7A9D48C05 Q37952006-1DD373D9-4697-4B1A-83C7-4E06C731A3F9 Q38137030-CE4571C8-FBBC-4A96-A5CC-0F8811749D3D Q38737293-4FE342B5-3537-4D31-96A8-47231EE902BE Q38948393-D27C1D30-0B93-44C5-9967-20C73616921D Q39080408-01B9DA9F-7DB0-42CB-BEAF-B13053DB33C7 Q39369084-77EA9C0F-74DA-4519-ADCD-1D28EA013683 Q39388749-6938967C-E4AA-436C-A42E-43C21584B92E Q39839292-84663282-3047-4E57-B437-3F620A21D905 Q39900071-E46ABDE0-2577-4CB0-9C28-5278E9C1BE9C Q39912602-2D774D06-4859-4A0B-BAE5-07EBE78A3201 Q39961341-4138A196-74EB-4257-A352-88AEB473E9B1 Q40011698-0F2EE9A3-8AF1-4621-8599-18C205780737 Q41129839-5A2ED48C-36DC-49A6-9ABA-7AD546F2CF74

P2860

Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

http://www.wikidata.org/entity/Q57942209

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2004

@uk

name

Human Kallikrein 6 Degrades Ex ...... atic Potential of Tumour Cells

@en

Human Kallikrein 6 Degrades Ex ...... atic Potential of Tumour Cells

@nl

type

label

Human Kallikrein 6 Degrades Ex ...... atic Potential of Tumour Cells

@en

Human Kallikrein 6 Degrades Ex ...... atic Potential of Tumour Cells

@nl

prefLabel

Human Kallikrein 6 Degrades Ex ...... atic Potential of Tumour Cells

@en

Human Kallikrein 6 Degrades Ex ...... atic Potential of Tumour Cells

@nl

P1433

Q57942209-4A287410-10A9-469C-BF75-E454523305CC

P1476

Q57942209-BA36B64C-A8E2-4C02-963F-C2A1C6DC9969

P2093

Q57942209-69829437-52CB-43FA-9EA5-F830FB3AE774

Q57942209-6E475347-2ED5-46D6-B9C1-3AC0E5D31C31

Q57942209-A489A702-6B33-476B-A5B1-7E2BCB8DCBC8

Q57942209-B0B25B27-63F8-4C20-BE10-90BB95746131

P2860

Q57942209-316BF40B-5477-454F-93A3-1BFED467409B

Q57942209-3D0BF9CB-2C39-413D-A0AA-D6A2147CA69F

Q57942209-4134603E-6B19-4E46-9121-891B6B3136F2

Q57942209-47835BB2-ACF8-4AFB-B444-E7A29885863D

Q57942209-4A07D3BB-BA5B-4DC0-81CB-45945562A55D

Q57942209-4A68964B-995F-4CB6-A63A-BA7027ECDB89

Q57942209-4C647B5A-3962-49DF-8A54-B3C1B623BD0B

Q57942209-4D5B5B37-DF35-4287-8306-F6C4B22E40EA

Q57942209-56877308-1B22-44AF-A839-6CFEC3F2CD4C

Q57942209-5E980F8A-5F09-4284-8C04-FE2A37FCFA2B

P2888

Q57942209-C2D5BB53-608B-484E-B364-18690B1B8B5D

P304

Q57942209-E0B45994-BBC8-4336-9D30-A9358783A902

P31

Q57942209-4A30A0ED-0EC5-4B30-864C-696712AE864B

P356

Q57942209-3888AE5F-8C7C-450E-9D9F-4B08D915128D

P433

Q57942209-17CCBEC9-463F-4B38-84BF-5E8DAE910246

P478

Q57942209-DDA81E18-40E2-42E3-B8FF-204AB73366ED

P50

Q57942209-4CE29B28-F7FA-4D5A-B547-562607B21D7D

P577

Q57942209-86938DFE-15C2-44CC-BECF-DBCDE5C70FB6

P6179

Q57942209-F4124B94-4D57-4E10-AC0C-244CD8009A1E

P698

Q57942209-B11A9B45-B0F9-4B39-B85B-9270E04AEAE5

P356

P1433

P1476

Human Kallikrein 6 Degrades Ex ...... atic Potential of Tumour Cells

@en

P2093

Antoninus Soosaipillai

http://www.w3.org/2001/XMLSchema#string

Georgia Sotiropoulou

http://www.w3.org/2001/XMLSchema#string

Linda Grass

http://www.w3.org/2001/XMLSchema#string

Manik C. Ghosh

http://www.w3.org/2001/XMLSchema#string

P2860

Form and function: the laminin family of heterotrimers

The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry

Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system

Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease

Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen

Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain

Role of vitronectin and its receptors in haemostasis and vascular remodeling

Macromolecular organization of basement membranes

P2888

P304

193-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000081102

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Eleftherios P. Diamandis

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021360769

http://www.w3.org/2001/XMLSchema#string

P698

15557757

http://www.w3.org/2001/XMLSchema#string